Goeritzer M, Kuentzel K, Beck S, Korbelius M, Rainer S, Bradic I
Int J Mol Sci. 2023; 24(4).
PMID: 36834530
PMC: 9958834.
DOI: 10.3390/ijms24043116.
Kawano T, Hisada Y, Grover S, Schug W, Paul D, Bergmeier W
Thromb Haemost. 2023; 123(5):501-509.
PMID: 36716775
PMC: 10820933.
DOI: 10.1055/s-0043-1761419.
Silva-Luis C, Alves J, de Oliveira J, de Sousa Luis J, Araujo I, Tavares J
Nutrients. 2022; 14(10).
PMID: 35631239
PMC: 9143840.
DOI: 10.3390/nu14102098.
Russell P, Hagemeyer C, Esser L, Voelcker N
Theranostics. 2022; 12(6):2773-2800.
PMID: 35401833
PMC: 8965493.
DOI: 10.7150/thno.70001.
Goeritzer M, Schlager S, Kuentzel K, Vujic N, Korbelius M, Rainer S
Cells. 2022; 11(5).
PMID: 35269472
PMC: 8908992.
DOI: 10.3390/cells11050850.
Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.
Lee R, Kawano T, Grover S, Bharathi V, Martinez D, Cowley D
J Thromb Haemost. 2021; 20(2):422-433.
PMID: 34689407
PMC: 8792346.
DOI: 10.1111/jth.15569.
Murine Models in the Evaluation of Heparan Sulfate-Based Anticoagulants.
Mohammed B, Cheng Q, Ivanov I, Gailani D
Methods Mol Biol. 2021; 2303:789-805.
PMID: 34626423
PMC: 8552346.
DOI: 10.1007/978-1-0716-1398-6_59.
Factor XIII deficiency does not prevent FeCl-induced carotid artery thrombus formation in mice.
Tang Z, Kattula S, Holle L, Cooley B, Lin F, Wolberg A
Res Pract Thromb Haemost. 2020; 4(1):111-116.
PMID: 31989092
PMC: 6971319.
DOI: 10.1002/rth2.12278.
The red blood cell death receptor and thrombosis.
Mackman N
J Clin Invest. 2018; 128(9):3747-3749.
PMID: 30102257
PMC: 6118588.
DOI: 10.1172/JCI122881.
Refinement of a mouse cardiovascular model: Development, application and dissemination.
Taylor K, Emerson M
F1000Res. 2018; 7:593.
PMID: 29904600
PMC: 5974574.
DOI: 10.12688/f1000research.14456.1.
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss.
Sheffield W, Eltringham-Smith L, Bhakta V
BMC Biotechnol. 2018; 18(1):21.
PMID: 29621998
PMC: 5887181.
DOI: 10.1186/s12896-018-0431-4.
The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis.
Branchford B, Stalker T, Law L, Acevedo G, Sather S, Brzezinski C
J Thromb Haemost. 2017; 16(2):352-363.
PMID: 29045015
PMC: 5858881.
DOI: 10.1111/jth.13875.
Leukaemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation.
Zou S, Teixeira A, Yin M, Xiang Y, Xavier-Ferrucio J, Zhang P
Thromb Haemost. 2016; 116(3):506-16.
PMID: 27345948
PMC: 5845781.
DOI: 10.1160/TH15-11-0848.
Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel.
Bonnard T, Hagemeyer C
J Vis Exp. 2015; (100):e52838.
PMID: 26167713
PMC: 4544968.
DOI: 10.3791/52838.
Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach.
Ciciliano J, Sakurai Y, Myers D, Fay M, Hechler B, Meeks S
Blood. 2015; 126(6):817-24.
PMID: 25931587
PMC: 4528067.
DOI: 10.1182/blood-2015-02-628594.
Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein.
Vu T, Zhou J, Leslie B, Stafford A, Fredenburgh J, Ni R
Blood. 2015; 125(17):2712-9.
PMID: 25691157
PMC: 4416941.
DOI: 10.1182/blood-2014-11-611319.
Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling.
Gong Y, Lin M, Piao L, Li X, Yang F, Zhang J
Br J Pharmacol. 2014; 172(23):5647-60.
PMID: 25339093
PMC: 4667862.
DOI: 10.1111/bph.12986.
Murine models in the evaluation of heparan sulfate-based anticoagulants.
Gailani D, Cheng Q, Ivanov I
Methods Mol Biol. 2014; 1229:483-96.
PMID: 25325974
PMC: 4365426.
DOI: 10.1007/978-1-4939-1714-3_37.
Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.
Zhu Q, Yamakuchi M, Ture S, Garcia-Hernandez M, Ko K, Modjeski K
J Clin Invest. 2014; 124(10):4503-16.
PMID: 25244095
PMC: 4191049.
DOI: 10.1172/JCI71245.
Plasmodium falciparum infection induces expression of a mosquito salivary protein (Agaphelin) that targets neutrophil function and inhibits thrombosis without impairing hemostasis.
Waisberg M, Molina-Cruz A, Mizurini D, Gera N, Sousa B, Ma D
PLoS Pathog. 2014; 10(9):e1004338.
PMID: 25211214
PMC: 4161438.
DOI: 10.1371/journal.ppat.1004338.